Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis

Huang Wu(Second Military Medical University), Changli Wang(Tianjin Medical University Cancer Institute and Hospital), Jiaxin Zhao(Second Military Medical University), Xinyu Li(Tianjin University), Jie Huang(Second Military Medical University), Wangzheqi Zhang(Second Military Medical University), Yalin Zhu(Second Military Medical University), Xiaoming Deng(Second Military Medical University), Jiale Cui(Zhoukou Normal University), Yuqi Feng(Second Military Medical University)
Cellular & Molecular Biology Letters
August 15, 2025
10.1186/s11658-025-00784-w
Cited by 18

Related Papers

Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
|Critical Care|2010|307
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
|Critical Care|2011|254
Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis
|Blood|2021|218
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
|Critical Care|2011|215